Developing Techniques for the Utilization of Planctomycetes As Producers of Bioactive Molecules.
Planctomycetes are conspicuous, ubiquitous, environmentally important bacteria. They can attach to various surfaces in aquatic habitats and form biofilms. Their unique FtsZ-independent budding cell division mechanism is associated with slow growth and doubling times from 6 h up to 1 month. Despite this putative disadvantage in the struggle to colonize surfaces, Planctomycetes are frequently associated with aquatic phototrophic organisms such as diatoms, cyanobacteria or kelp, whereby Planctomycetes can account for up to 50% of the biofilm-forming bacterial population. Consequently, Planctomycetes were postulated to play an important role in carbon utilization, for example as scavengers after phototrophic blooms. However, given their observed slow growth, such findings are surprising since other faster- growing heterotrophs tend to colonize similar ecological niches. Accordingly, Planctomycetes were suspected to produce antibiotics for habitat protection in response to the attachment on phototrophs. Recently, we demonstrated their genomic potential to produce non-ribosomal peptides, polyketides, bacteriocins, and terpenoids that might have antibiotic activities. In this study, we describe the development of a pipeline that consists of tools and procedures to cultivate Planctomycetes for the production of antimicrobial compounds in a chemically defined medium and a procedure to chemically mimic their interaction with other organisms such as for example cyanobacteria. We evaluated and adjusted screening assays to enable the hunt for planctomycetal antibiotics. As proof of principle, we demonstrate antimicrobial activities of planctomycetal extracts from Planctopirus limnophila DSM 3776, Rhodopirellula baltica DSM 10527, and the recently isolated strain Pan216. By combining UV/Vis and high resolution mass spectrometry data from high-performance liquid chromatography fractionations with growth inhibition of indicator strains, we were able to assign the antibiotic activity to candidate peaks related to planctomycetal antimicrobial compounds. The MS analysis points toward the production of novel bioactive molecules with novel structures. Consequently, we developed a large scale cultivation procedure to allow future structural elucidation of such compounds. Our findings might have implications for the discovery of novel antibiotics as Planctomycetes represent a yet untapped resource that could be developed by employing the tools and methods described in this study.
Department of Microbial Cell Biology and Genetics, Leibniz Institute DSMZ, Braunschweig Germany.
Olga
O
Jeske
Department of Microbial Drugs, Helmholtz Centre for Infection Research, BraunschweigGermany; German Centre for Infection Research Association, Partner Site Hannover-Braunschweig, BraunschweigGermany.
Frank
F
Surup
Department of Microbial Cell Biology and Genetics, Leibniz Institute DSMZ, Braunschweig Germany.
Marcel
M
Ketteniß
Department of Microbial Cell Biology and Genetics, Leibniz Institute DSMZ, Braunschweig Germany.
Patrick
P
Rast
Department of Microbial Drugs, Helmholtz Centre for Infection Research, BraunschweigGermany; German Centre for Infection Research Association, Partner Site Hannover-Braunschweig, BraunschweigGermany.
Birthe
B
Förster
Department of Microbial Cell Biology and Genetics, Leibniz Institute DSMZ, Braunschweig Germany.
Mareike
M
Jogler
Department of Microbial Drugs, Helmholtz Centre for Infection Research, Braunschweig Germany.
Joachim
J
Wink
Department of Microbial Cell Biology and Genetics, Leibniz Institute DSMZ, Braunschweig Germany.
Christian
C
Jogler
Planctomycetes; Planctopirus limnophila; Rhodopirellula baltica; antibiotics; natural products; screening; secondary metabolites